Global X Genomics & Biotechnology ETF Rating $45.55 -0.76 (-1.64%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.60Holdings in GNOM have an aggregate rating of Moderate Buy based on 438 analyst ratings issued in the past year covering 23 companies (84.2% of the portfolio).GNOM Aggregate Price Target$45.55High Prediction$45.55Average Prediction$45.55Low Prediction$45.55Holdings in GNOM have an aggregate price target of $45.55 and a range of $45.55 to $45.55 covering 23 companies (84.2% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GNOM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.33%MRNAModerna$46.71-1.2%1.138 of 5 stars1.84$35.73 -23.5%19Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision7.19%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6361 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings6.56%PRAXPraxis Precision Medicines$333.30-1.3%3.3965 of 5 stars3.00$590.78 77.3%20Positive News5.14%ILMNIllumina$139.07-0.2%3.0776 of 5 stars2.22$131.06 -5.8%18Earnings ReportAnalyst Forecast4.74%GHGuardant Health$89.52-1.8%3.8634 of 5 stars2.86$128.63 43.7%21News CoverageUpcoming Earnings4.06%NTRANatera$206.77-2.3%4.1795 of 5 stars2.79$253.47 22.6%19Upcoming Earnings4.06%VRTXVertex Pharmaceuticals$424.36-1.3%4.6035 of 5 stars2.83$554.83 30.7%29Trending NewsEarnings ReportAnalyst DowngradeInsider Trade4.05%BMRNBioMarin Pharmaceutical$53.24-4.0%4.5105 of 5 stars2.77$90.32 69.6%22Trending NewsAnalyst ForecastHigh Trading Volume3.98%BNTXBioNTech$95.50-3.9%4.1137 of 5 stars2.72$133.13 39.4%18News CoveragePositive NewsEarnings ReportGap Down3.44%CRSPCRISPR Therapeutics$52.38-2.2%2.4594 of 5 stars2.53$64.53 23.2%19Trending NewsEarnings ReportUpcoming Earnings3.28%TECHBio-Techne$56.68+3.5%4.2711 of 5 stars2.71$72.77 28.4%14Positive NewsUpcoming EarningsGap Up3.10%TWSTTwist Bioscience$56.70+0.9%1.2066 of 5 stars2.60$53.00 -6.5%10Trending NewsEarnings ReportAnalyst ForecastGap Up2.98%QGENQiagen$33.98+0.1%4.544 of 5 stars2.50$47.09 38.6%12Upcoming Earnings2.91%LEGNLegend Biotech$28.51+7.6%3.3378 of 5 stars2.67$58.31 104.5%15News CoverageUpcoming EarningsHigh Trading Volume2.70%BMYBristol Myers Squibb$56.94-0.8%4.7086 of 5 stars2.37$61.31 7.7%19Trending NewsEarnings Report2.54%ALNYAlnylam Pharmaceuticals$301.11+1.1%4.3471 of 5 stars2.81$471.96 56.7%26Earnings ReportAnalyst Upgrade2.51%BEAMBeam Therapeutics$28.90-3.9%2.8931 of 5 stars2.75$49.36 70.8%162.33%VCYTVeracyte$32.97-1.4%3.2327 of 5 stars2.38$43.83 32.9%8News CoverageEarnings ReportHigh Trading Volume2.20%GILDGilead Sciences$133.48+0.6%4.836 of 5 stars2.86$157.35 17.9%28Trending NewsUpcoming Earnings2.20%LLYEli Lilly and Company$989.02+2.2%4.8771 of 5 stars2.87$1,217.59 23.1%30Trending NewsEarnings ReportDividend AnnouncementAnalyst Upgrade2.16%TXG10x Genomics$22.01+1.7%1.2923 of 5 stars2.29$20.82 -5.4%17Upcoming EarningsGap Up1.99%RAREUltragenyx Pharmaceutical$25.01+0.8%3.2948 of 5 stars2.83$60.76 143.0%18News CoverageEarnings ReportAnalyst UpgradeInsider Trade1.72%SRPTSarepta Therapeutics$21.79-1.1%3.2013 of 5 stars2.11$32.63 49.7%28Upcoming Earnings This page (NASDAQ:GNOM) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
